
New therapies in breast cancer, particularly ADCs, present unique safety profiles for nurses to be aware of, according to Erika Hamilton, MD.
Erika Hamilton is the director of breast and gynecologic cancer research at Sarah Cannon Research Institute in Nashville, Tennessee.

Published: July 14th 2025 | Updated: